Zidovudine Phosphorylation Determined Sequentially over 12 Months in Human Immunodeficiency Virus-Infected Patients with or without Previous Exposure to Antiretroviral Agents

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2001-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/AAC.35.3.976-980.2001PMID 11181396PMCID PMC90409
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Determinants of virological response to antiretroviral therapy: implications for long-term strategies.

  2000cited by this paper
• Pharmacokinetics of Zidovudine Phosphorylation in Human Immunodeficiency Virus-Positive Thai Patients and Healthy Volunteers

  2000cited by this paper
• The effect of zidovudine dose on the formation of intracellular phosphorylated metabolites

  1996cited by this paper
• Long-Term Exposure to Zidovudine Affects in Vitro and in Vivo the Efficiency of Phosphorylation of Thymidine Kinase

  1996cited by this paper
• Zidovudine phosphorylation after short‐term and long‐term therapy with zidovudine in patients infected with the human immunodeficiency virus

  1996influential reference
• Development of zidovudine (AZT) resistance in Jurkat T cells is associated with decreased expression of the thymidine kinase (TK) gene and hypermethylation of the 5' end of human TK gene.

  1995cited by this paper
• Decreased Thymidine Kinase Levels in Peripheral Blood Cells from HIV-Seropositive Individuals: Implications for Zidovudine Metabolism

  1995cited by this paper
• Zidovudine phosphorylation in HIV‐infected patients and seronegative volunteers

  1994cited by this paper
• Anti-human immunodeficiency virus type 1 activity of hydroxyurea in combination with 2',3'-dideoxynucleosides.

  1994cited by this paper
• Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replication.

  1994cited by this paper
• Correlates of zidovudine phosphorylation with markers of HIV disease progression and drug toxicity

  1994cited by this paper
• Evidence of in vitro development of drug resistance to azidothymidine in T-lymphocytic leukemia cell lines (Jurkat E6-1/AZT-100) and in pediatric patients with HIV-1 infection.

  1993cited by this paper
• Concentrations of Phosphorylated Zidovudine (ZDV) in Patient Leukocytes Do Not Correlate with ZDV Dose or Plasma Concentrations

  1991influential reference

• Regulation of expression and activity of hepatic transporters by pregnancy-related hormones in HepaRG cells.

  2025cites this paper
• Cellular pharmacology of tenofovir alafenamide and emtricitabine in neutrophils and platelets in people with and without HIV.

  2025cites this paper
• Intracellular Tenofovir and Emtricitabine Concentrations in Younger and Older Women with HIV Receiving Tenofovir Disoproxil Fumarate/Emtricitabine

  2020cites this paper
• Joint Population Pharmacokinetic Analysis of Zidovudine, Lamivudine, and Their Active Intracellular Metabolites in HIV Patients

  2011cites this paper
• Intracellular Pharmacokinetics of Antiretroviral Drugs in HIV-Infected Patients, and their Correlation with Drug Action

  2010cites this paper
• Lack of association between stavudine exposure and lipoatrophy, dysglycaemia, hyperlactataemia and hypertriglyceridaemia: a prospective cross sectional study

  2010cites this paper
• Development of an Optimized Dose for Coformulation of Zidovudine with Drugs That Select for the K65R Mutation Using a Population Pharmacokinetic and Enzyme Kinetic Simulation Model

  2008cites this paper
• Pharmacokinetics of Reverse Transcriptase Inhibitors

  2006cites this paper
• Effect of Ribavirin on Intracellular and Plasma Pharmacokinetics of Nucleoside Reverse Transcriptase Inhibitors in Patients with Human Immunodeficiency Virus-Hepatitis C Virus Coinfection: Results of a Randomized Clinical Study

  2005influential citation
• Lack of Reduction of Thymidine Kinase Activity in Stavudine-Treated HIV-Infected Patients

  2004cites this paper
• The cellular pharmacology of nucleoside- and nucleotide-analogue reverse-transcriptase inhibitors and its relationship to clinical toxicities.

  2004influential citation
• Enzymatic Assay for Measurement of Intracellular DXG Triphosphate Concentrations in Peripheral Blood Mononuclear Cells from Human Immunodeficiency Virus Type 1-Infected Patients

  2003cites this paper
• Antiviral dynamics and sex differences of zidovudine and lamivudine triphosphate concentrations in HIV-infected individuals

  2003cites this paper
• Development of Enzymatic Assays for Quantification of Intracellular Lamivudine and Carbovir Triphosphate Levels in Peripheral Blood Mononuclear Cells from Human Immunodeficiency Virus-Infected Patients

  2002cites this paper
• Intracellular pharmacology of nucleoside analogues and protease inhibitors: role of transporter molecules

  2002cites this paper
• Combinations against combinations: associations of anti-HIV 1 reverse transcriptase drugs challenged by constellations of drug resistance mutations.

  2002cites this paper